Quality should be built into manufacturing systems instead of being imposed as a corrective action.
Michele Burd
Advertisement
Articles by Michele Burd
Advertisement
Latest Updated Articles
After the Consent Decree — An Uphill Battle for Affected CompaniesPublished: June 1st 2004 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
